Biotechs Use Equity Grants to Recruit Talent

Public companies recruiting specialized staff can issue equity to new hires without a shareholder vote under Nasdaq rules.

Updated on Nov. 3, 2026 in Public Companies

Bold flat-color economist-style editorial illustration of stepped solid blocks rising in a staggered row, depicting a vesting schedule.
Monte Rosa Therapeutics granted inducement equity awards covering 33,775 options and 7,400 RSUs to four new hires under Nasdaq's new-hire exception. AI Illustration. Upload story photo >

Monte Rosa Therapeutics granted inducement equity awards to four newly hired non-executive employees, covering options for 33,775 shares and 7,400 restricted stock units. The awards were made outside stockholder-approved plans under Nasdaq's new-hire inducement exception, which affects public biotech companies managing equity compensation for recruits.

Why it matters

Public companies can use inducement grants to recruit talent without a shareholder vote when the awards are a material inducement to joining. For operators, this shows how equity is used as a hiring tool, with vesting schedules structured to keep new hires tied to the company for several years.

The filing covers options on 33,775 shares priced at $10.63 and 7,400 restricted stock units granted to four new non-executive hires. The options vest 25% after one year and then in 36 equal monthly installments, while the RSUs vest 25% annually over four years.

The players

Monte Rosa Therapeutics, Inc.

A Boston-based clinical-stage biotechnology company that develops targeted protein degradation therapies and is listed on Nasdaq.

Nasdaq

The U.S. stock exchange that sets listing rules, including the inducement grant exception that allows public companies to issue equity to new hires without shareholder approval.

The details

Because the grants were made outside stockholder-approved equity plans, Monte Rosa relied on the 2026 Inducement Plan and approval from its compensation committee, which is made up solely of independent directors. Under Nasdaq Listing Rule 5635(c)(4), such awards must be a material inducement to employment. The staggered vesting, with a one-year cliff followed by monthly vesting for options and annual vesting for RSUs, encourages new hires to remain with the company over multiple years.

Timeline

  1. November 2, 2026: Nasdaq closing price used to set the option exercise price and establish the grant date.

  2. November 3, 2026: Monte Rosa announced the inducement equity awards.

Market Landscape

Nasdaq Listing Rule 5635(c)(4) allows listed companies to grant inducement awards to new hires without a shareholder vote, provided the awards are a material inducement to employment. Monte Rosa's grants follow this established pattern used across public companies that compete for scarce specialized talent.

Operators at public companies should note that inducement grants can bring in new hires without a shareholder vote, but they must be tied to employment and approved by an independent committee. Companies weighing equity-based recruiting should review the vesting structure and Nasdaq's requirements with qualified counsel.

The takeaway

Equity-based inducement awards remain a flexible recruiting tool for public companies, with vesting schedules designed to retain new hires. Operators watching talent costs should track how often companies use the Rule 5635(c)(4) exception and the dilution it creates over time.

Further reading

For more on how listed companies manage equity and hiring, see Public Companies coverage.